{
  "title": "Recession Ahead? Plus, an Obesity Breakthrough.",
  "description": "Why Eli Lilly and Novo Nordisk are headed for weight loss riches. And a top strategist shares moves to make now.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "pubDate": "Fri, 10 Jun 2022 23:24:00 -0000",
  "itunes:episodeType": "full",
  "itunes:author": "Barron's",
  "itunes:subtitle": "",
  "itunes:summary": "Why Eli Lilly and Novo Nordisk are headed for weight loss riches. And a top strategist shares moves to make now.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "content:encoded": "<p>Why Eli Lilly and Novo Nordisk are headed for weight loss riches. And a top strategist shares moves to make now.</p><p> </p><p>Learn more about your ad choices. Visit <a href=\"https://megaphone.fm/adchoices\">megaphone.fm/adchoices</a></p>",
  "itunes:duration": 1411,
  "guid": "f3006294-e92e-11ec-9de4-23003267a901",
  "enclosure": ""
}